- Elephantiasis, also known as lymphatic filariasis (LF), affects around 120 million people globally and leads to severe physical deformities, impacting quality of life and socio-economic status, particularly in Southern Africa.
- LF is endemic in four Southern African Development Community (SADC) countries, with some regions facing challenges in mass drug administration (MDA) efforts, while Malawi has successfully eliminated LF as a public health problem.
- Gaps in knowledge about LF prevalence in the SADC region highlight the need for ongoing research, improved data collection, and effective policies to combat the disease and enhance healthcare infrastructure.